Liu, Ming <br/><br/>
A hepatocyte differentiation model reveals two subtypes of liver cancer with different oncofetal properties and therapeutic targets.  [electronic resource] 

 -  Proceedings of the National Academy of Sciences of the United States of America  03 2020 
 - 6103-6113 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1091-6490 
<br/><br/><label>Standard No.: </label>10.1073/pnas.1912146117  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aminopyridines--pharmacology<br/>Animals<br/>Biomarkers, Tumor--antagonists & inhibitors<br/>Carcinoma, Hepatocellular--genetics<br/>Cell Differentiation--drug effects<br/>Cell Line<br/>Cell Transformation, Neoplastic--drug effects<br/>Cohort Studies<br/>Disease-Free Survival<br/>E2F1 Transcription Factor--antagonists & inhibitors<br/>Female<br/>Gene Expression Profiling<br/>Gene Expression Regulation, Developmental<br/>Gene Expression Regulation, Neoplastic<br/>Hepatectomy<br/>Hepatocytes--pathology<br/>Human Embryonic Stem Cells<br/>Humans<br/>Hydroxyquinolines--pharmacology<br/>Isoquinolines--pharmacology<br/>Kaplan-Meier Estimate<br/>Liver--growth & development<br/>Liver Neoplasms--genetics<br/>Male<br/>Mice<br/>Middle Aged<br/>Prognosis<br/>Pyridines--pharmacology<br/>Pyrroles--pharmacology<br/>Signal Transduction--genetics<br/>Smad3 Protein--antagonists & inhibitors<br/>Xenograft Model Antitumor Assays